ArticleJournal of translational medicine2025
The role of irregular eating behaviors in metabolic dysfunction-associated steatotic liver disease: evidence from a multicenter cross-sectional study in China.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Insulin resistance: mechanisms and therapeutic interventions.Molecular biomedicine · 2026Review
- Dietary Behavior Clustering and Cardiovascular Risk Markers in a Large Population Cohort.Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundIrregular eating patterns, such as skipping breakfast and late dinner consumption, have been linked to adverse metabolic profiles. However, the impact of these behaviors or their combined effect on metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear.
methodsIn this multicenter cross-sectional study, we analyzed data from 1965 adults recruited from diabetes, obesity, and metabolic disease clinics in six municipalities/provinces in China. Participants were categorized for analysis based on two irregular eating habits assessed by monthly frequency: skipping breakfast and late dinner consumption. For individual analyses, each habit was treated as a binary variable, dividing participants into two groups (e.g., skippers vs. non-skippers). For the combined analysis, these habits were aggregated to form a three-level ordinal variable, which classified participants based on the number of habits they reported: "No" (zero), "Medium" (one), or "Severe" (both). We employed logistic regression models to calculate the odds ratios (ORs) for MASLD associated with skipping breakfast, late dinner consumption, and their combination, after adjusting for key demographic, lifestyle, and metabolic factors.
resultsThe prevalence of MASLD was higher among breakfast skippers compared to those who ate breakfast regularly (52.9% vs. 47.2%, p = 0.023), and similarly higher among late dinner eaters compared to those with regular dinner times (54.4% vs. 46.8%, p = 0.003). In the combined analysis, a graded relationship was observed across the three-level ordinal variable, with MASLD prevalence increasing from 46.5% in the "No" irregular eating group, to 50.3% in the "Medium" irregular eating group, and 55.5% in the "Severe" irregular eating group (p = 0.01). After multivariable adjustment, skipping breakfast, late dinner consumption, and the combination of these behaviors were each independently associated with higher odds of MASLD. This was highlighted by a clear dose-response relationship for the combined behaviors, where the odds of MASLD systematically increased with the severity of irregular eating (from "No" to "Medium" to "Severe"). Notably, the "Severe" irregular eating group, representing those with both habits, had a 65% higher odds of MASLD compared to those with none (OR = 1.65, 95% CI 1.17-2.34, p = 0.004).
conclusionsOur study indicates that irregular eating behaviors, such as skipping breakfast and late dinner consumption, as well as their combination, are significantly associated with a higher prevalence of MASLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.